• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

New device developed at UBC could improve cancer detection

Bioengineer by Bioengineer
May 11, 2016
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

A new UBC-developed method to isolate cancer cells that have escaped from a tumour could soon pave the way for improved diagnosis and treatment.

The simple process involves a special device that squeezes cells in a blood sample through tiny funnels, which drive the cancer cells and blood cells into separate streams based on differences in their size and softness.

“Circulating tumour cells–cells from a tumour that have escaped into the bloodstream with the potential to spread into other tissues–are extremely useful for assessing a patient’s disease in order to select the most appropriate treatment,” said UBC mechanical engineering professor Hongshen Ma, the lead researcher. “These cells are particularly important for prostate cancer, where the site of metastasis is typically in the bone, where biopsies are difficult or impossible.”

Ma’s research focus is microfluidics, the flow of liquids through channels smaller than a human hair. The microfluidic device designed by his team captures cells based on their distinct internal structure–a mechanical analysis instead of the blood chemistry analysis used in conventional medical diagnostic techniques.

The device was first tested using blood samples spiked with cancer cells. It was then used to analyze blood samples from 20 patients with metastatic castration-resistant prostate cancer, an advanced form of cancer, and from four healthy individuals.

“In the first experiment, the device was able to capture more than 90 per cent of the cells,” noted co-author Dr. Kim N. Chi, director of clinical research at the B.C. Cancer Agency and a professor of medicine at UBC. “Importantly, in patient samples the device captured about 25 times the number of cancer cells and produced fewer false positives compared to the conventional CellSearch system, which also analyzes blood samples.”

The team is currently working on genome sequencing of individual circulating tumour cells from patients at the Vancouver Prostate Centre. This would allow researchers to determine the mutations responsible for metastasis so that doctors can select the most appropriate treatment.

###

“Continuous Flow Deformability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets” was published Feb. 24, 2016 in the journal Small. Click here to download a copy.

Media Contact

Lou Bosshart
[email protected]
604-999-0473
@UBCnews

http://www.ubc.ca

The post New device developed at UBC could improve cancer detection appeared first on Scienmag.

Share31Tweet8Share2ShareShareShare2

Related Posts

Federal and Industry Sponsors Play Complementary Roles in Cancer Clinical Trials

August 21, 2026

Mathematics and medicine unite to unravel cancer’s enduring mystery

August 21, 2026

Mount Sinai Finds Chemo-Free Treatment Promising for Some Metastatic Breast Cancer Patients

August 21, 2026

ACCESS Study Expands Potential Stem Cell Donor Options for Blood Cancer Patients

August 21, 2026
Please login to join discussion

POPULAR NEWS

  • AI model predicts which patients benefit most from exercise-based cardiac rehabilitation

    29 shares
    Share 12 Tweet 7
  • Bioengineered Acellular Regenerative Conduit Maintains Coronary Bypass Patency for 18 Months

    29 shares
    Share 12 Tweet 7
  • Proteomic Atlas Maps Obesity Reversal Across Organs in Male Mice

    29 shares
    Share 12 Tweet 7
  • Assessing Early-Onset Sepsis Risk in Extremely Preterm Infants to Improve Antibiotic Stewardship

    29 shares
    Share 12 Tweet 7

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AI model predicts which patients benefit most from exercise-based cardiac rehabilitation

Bioengineered Acellular Regenerative Conduit Maintains Coronary Bypass Patency for 18 Months

Proteomic Atlas Maps Obesity Reversal Across Organs in Male Mice

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.